Top Markets
Coin of the day
Merck & Co., Inc. Merck & Co., Inc.

Merck & Co., Inc.

MRK
Classificação em ações #40
Merck & Co., Inc. is a global healthcare leader with operations spanning two... Merck & Co., Inc. is a global healthcare leader with operations spanning two core divisions: Pharmaceuticals and Animal Health. The Pharmaceutical segment is dedicated to human health, offering a broad spectrum of medicinal products. These cover crucial therapeutic areas such as oncology, acute hospital care, immunology, neuroscience, virology, cardiovascular conditions, and diabetes. This division also develops vital preventive vaccines for pediatric, adolescent, and adult populations. Meanwhile, the Animal Health segment focuses on the research, development, manufacturing, and marketing of veterinary medications, vaccines, and comprehensive health management solutions for animals. This division further provides innovative digital products designed for animal identification, traceability, and continuous monitoring. Merck's extensive clientele encompasses drug wholesalers, pharmacies, hospitals, and government agencies. It also serves managed healthcare organizations, including health maintenance organizations (HMOs) and pharmacy benefit managers, as well as various other institutional clients. Additionally, the company supplies products to individual physicians and their distributors, veterinarians, and livestock producers. The organization actively engages in strategic collaborations with companies such as AstraZeneca PLC, Bayer AG, Eisai Co., Ltd., Ridgeback Biotherapeutics, and Gilead Sciences, Inc. These partnerships are specifically aimed at the joint development and commercialization of prolonged-acting therapies for HIV. Established in 1891, Merck & Co., Inc. maintains its corporate headquarters in Kenilworth, New Jersey.
Preço da ação
$152.40
Valor de mercado
$376.40B
Variação (1 dia)
12.48%
Variação (1 ano)
79.44%
País
US
Negociar Merck & Co., Inc. (MRK)

Categoria

Receita da Merck & Co., Inc. (MRK)
Receita em Jun 2026 TTM: $66.40B
De acordo com os últimos relatórios financeiros da Merck & Co., Inc., a receita atual da empresa (TTM) é $66.40B. Em 2024, a empresa obteve uma receita de $64.17B um aumento em relação a a receita do ano 2023, que foi de $60.12B. A receita é o valor total gerado pela venda de bens ou serviços. Ao contrário do lucro, nenhuma despesa é subtraída.
Histórico de receita da Merck & Co., Inc. de 2000 a 2026
Receita no final de cada ano
Ano Receita Alterar
2026 (TTM) $66.40B 2.14%
2025 $65.01B 1.31%
2024 $64.17B 6.74%
2023 $60.12B 1.40%
2022 $59.28B 21.72%
2021 $48.70B 17.31%
2020 $41.52B 6.13%
2019 $39.12B -7.50%
2018 $42.29B 5.41%
2017 $40.12B 0.79%
2016 $39.81B 0.78%
2015 $39.50B -6.48%
2014 $42.24B -4.08%
2013 $44.03B -6.84%
2012 $47.27B -1.62%
2011 $48.05B 4.48%
2010 $45.99B 67.66%
2009 $27.43B 15.00%
2008 $23.85B -1.44%
2007 $24.20B 6.90%
2006 $22.64B 2.84%
2005 $22.01B -4.18%
2004 $22.97B 2.17%
2003 $22.49B 4.85%
2002 $21.45B 1.16%
2001 $21.20B -47.48%
2000 $40.36B 0.00%
Receita de empresas similares ou concorrentes
Empresa Receita Diferença de Receita País
$79.67B 19.98%
US
$97.93B 47.48%
US
$64.39B -3.03%
US
$77.52B 16.74%
CH
$56.26B -15.27%
CH